Tablets of 7- (3'- (methylhydroxyethylamino) -2'-hydroxypropyl) -theophylline nicotinate with delayed action. I. Moderation of the release of the active substance by some additives
Pawlak, E.; Chodkowska-Granicka, B.; Surowiecki, J.
Acta Poloniae Pharmaceutica 28(1): 43-47
1971
ISSN/ISBN: 0001-6837 PMID: 5577811 Document Number: 33693
Document emailed within 1 workday
Related Documents
Chodkowska-Granicka, B.; Pawlak, Z.; Pawlak, E.; Surowiecki, J. 1972: Tablets of 7-(3'-(methylhydroxylethylamino)-2'-hydroxypropyl)-theophylline nicotinate with prolonged action. II. Retardation of the drug release by polymer coating of tablets Acta Poloniae Pharmaceutica 29(6): 618-622Baronti, A.; Verdiani, P.; Di Carlo, S. 1987: Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily La Clinica Terapeutica 122(6): 437-440
Qadan, A.; Süss, W. 2000: Controlled release of carbamazepine from pellets and tablets manufactured with hydroxypropyl methylcellulose Die Pharmazie 55(8): 628
Rabiant, J.; Soulairac, A.; Dorme, N. 1972: Urinary excretion of heptaminol after ingestion of conventional tablets and delayed-action tablets Annales Pharmaceutiques Francaises 30(9): 601-609
Mellstrand, T.; Svedmyr, N.; Fagerström, P.O. 1980: Absorption of theophylline from conventional and sustained-release tablets European Journal of Respiratory Diseases. Supplement 109: 54-60
Selmeczi, B.; Kedvessy, G.; Nagy, G.; Pintyéné Hódi, K.; Tencova, A.; Kiszeleva, G. 1981: Influence of the technological procedure and additives on the dissolution rate and absorption of active ingredients. I. Physical properties of acetylsalicylic acid tablets and of the dissolution rate of the active ingredient Acta Pharmaceutica Hungarica 51(5): 222-227
Jonkman, J.H.; van der Boon, W.J.; Schoenmaker, R.; Holtkamp, A.; Thürkow-Luikens, A.J. 1984: The absolute bioavailability of a new pediatric sustained release theophylline tablet, when given as whole or divided tablets International Journal of Clinical Pharmacology Therapy and Toxicology 22(9): 506-510
McKenzie, S.; Baillie, E. 1979: Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets) Journal of International Medical Research 7(Suppl 1): 22-27
Kaiko, R.F.; Fitzmartin, R.D.; Thomas, G.B.; Goldenheim, P.D. 1992: The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets PharmacoTherapy 12(2): 107-113
Reinberg, A.; Pauchet, F.; Ruff, F.; Gervais, P.; Levi, F.; Gervais, A.; Smolensky, M.; Chaouat, D.; Zidani, R.; Abella, M.L. 1986: Use of a delayed-action theophylline for a single ingestion: morning or evening? Presse Medicale 15(12): 581
von Schrader, H.W.; Buscher, G.; Dierdorf, D.; Freytag, A.; Mügge, H.; Wolf, D. 1985: Bioavailability and tolerance of xanthinol nicotinate depot preparations. Comparison of a conventional 500 mg xanthinol nicotinate depot tablet with new 500 mg and 1 g depot tablets Arzneimittel-Forschung 35(9): 1468-1472
Brazier, J.L.; Comet, F.; Bannier, A.; Gillet, A.; Georges, D. 1985: Comparison between in vitro dissolution and in vivo absorption of a new form of delayed-action theophylline Annales Pharmaceutiques Francaises 43(1): 55-60
Philip-Joet, F.; Bruguerolle, B.; Parrel, M.; Vestri, R.; Arnaud, A. 1988: Time-related distribution of delayed-action theophylline in the treatment of chronic obstructive bronchopneumopathies Presse Medicale 17(5): 193-196
Alciato, P.; Cantone, P.A.; Fico, D.; Gagliardini, R.; Petrella, V. 1990: Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride Minerva Medica 81(1-2): 93-97
Ervik, M. 1970: Gas chromatographic determination of 7-(beta-hydroxypropyl) theophylline in biological fluids Acta Pharmaceutica Suecica 7(6): 697-700
Mano, K. 1996: The development of slow-release theophylline products and revaluation of theophylline's role as a bronchodilator Nihon Rinsho. Japanese Journal of Clinical Medicine 54(11): 3093-3101
Rachelefsky, G.S.; Katz, R.M.; Siegel, S.C. 1978: A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels Annals of Allergy 40(4): 252-257
Gottmann-Lückerath, I. 1983: Clinico-experimental study on the start of the pharmacological action of an oral classical antihistaminic without and with delayed-action effect on the length of effect of the delayed-action type Die Medizinische Welt 34(18): 548-551
Tomassini, L.; Michailova, D.; Naplatanova, D.; Slavtschev, P. 1979: The effects of various factors on the in vitro velocity of drug release from repository tablets. Part 4: Isoniazid (Rimicid) respository tablets Die Pharmazie 34(12): 812-814
Walker, J.; Abdulsalam, A.; Theobald, A.E.; Subrahmanyam, R.; Verma, S.K. 1978: Multiple-scored tablets. Weight and content uniformity of subdivisions and distribution of active constituent within and between tablets Journal of Pharmacy and Pharmacology 30(7): 401-406